Literature DB >> 34121487

Thromboelastography (TEG) results are predictive of ischemic and hemorrhagic complications in patients with unruptured intracranial aneurysms treated with flow diversion.

Kainaat Javed1, Santiago R Unda2, Ryan Holland1, Adisson Fortunel1, Rose Fluss1, Julio Inocencio1, Neil Haranhalli1, David Altschul1.   

Abstract

INTRODUCTION: Flow diversion is an effective treatment modality for intracranial aneurysms but is associated with ischemic and hemorrhagic complications. Patients treated with flow diversion require dual antiplatelet therapy and subsequent platelet function tests. At our institution, Thromboelastography with Platelet Mapping (TEG-PM) is the test of choice. The primary objective of this study was to identify TEG parameters that are predictive of postoperative complications in patients treated with elective flow diversion.
METHODS: This was a retrospective study of 118 patients with unruptured intracranial aneurysms treated with flow diversion. Data was collected via chart review. Bivariate analyses were performed to identify significant variables in patients who suffered an ischemic stroke or a groin hematoma. ROC curves were constructed for the TEG parameters with statistical significance. Bivariate analyses were repeated using dichotomized TEG results.
RESULTS: Patients who experienced a symptomatic ischemic stroke had a history of stroke (p value = 0.007), larger aneurysm neck width (p value = 0.017), and a higher alpha angle (p value = 0.013). Cut off point for ischemic complication is 63° on ROC curve with a sensitivity of 100% and specificity of 65%. Patients who experienced a groin hematoma were no different from their healthy peers but had a lower alpha angle (p value = 0.033). Cut off point for hemorrhagic complication is 53.3° with a sensitivity of 82% and specificity of 67%.
CONCLUSION: The Alpha Angle parameter of TEG-PM has a sizeable predictive ability for both ischemic complications of the central nervous system and hemorrhagic complications of the access site after elective flow diversion.

Entities:  

Keywords:  Intracranial aneurysm; flow diversion; ischemic hemorrhagic complication

Mesh:

Year:  2021        PMID: 34121487      PMCID: PMC9131499          DOI: 10.1177/15910199211025917

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.764


  16 in total

1.  Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping.

Authors:  Brian M Corliss; Adam J Polifka; Neil S Harris; Brian L Hoh; W Christopher Fox
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

2.  Antiplatelet Therapy in Flow Diversion.

Authors:  Daniel A Tonetti; Brian T Jankowitz; Bradley A Gross
Journal:  Neurosurgery       Date:  2020-01-01       Impact factor: 4.654

Review 3.  Complications of endovascular treatment for intracranial aneurysms: Management and prevention.

Authors:  Yon Kwon Ihn; Shang Hun Shin; Seung Kug Baik; In Sup Choi
Journal:  Interv Neuroradiol       Date:  2018-02-21       Impact factor: 1.610

4.  High Risk of One-year Stroke Recurrence in Patients with Younger Age and Prior History of Ischemic Stroke.

Authors:  Jiann-Der Lee; Ya-Han Hu; Meng Lee; Yen-Chu Huang; Ya-Wen Kuo; Tsong-Hai Lee
Journal:  Curr Neurovasc Res       Date:  2019       Impact factor: 1.990

5.  Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis.

Authors:  Ebunoluwa Ajadi; Shaowli Kabir; Aaron Cook; Stephen Grupke; Abdulnasser Alhajeri; Justin F Fraser
Journal:  J Neurointerv Surg       Date:  2019-04-20       Impact factor: 5.836

Review 6.  Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review.

Authors:  Pavlos Texakalidis; Kimon Bekelis; Elias Atallah; Stavropoula Tjoumakaris; Robert H Rosenwasser; Pascal Jabbour
Journal:  Clin Neurol Neurosurg       Date:  2017-08-18       Impact factor: 1.876

Review 7.  Complications associated with the use of flow-diverting devices for cerebral aneurysms: a systematic review and meta-analysis.

Authors:  Geng Zhou; Ming Su; Yan-Ling Yin; Ming-Hua Li
Journal:  Neurosurg Focus       Date:  2017-06       Impact factor: 4.047

8.  Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.

Authors:  Ryan A McTaggart; Omar A Choudhri; Mary L Marcellus; Tom Brennan; Gary K Steinberg; Robert L Dodd; Huy M Do; Michael P Marks
Journal:  J Neurointerv Surg       Date:  2014-04-16       Impact factor: 5.836

9.  Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.

Authors:  Robert S Heller; Venkata Dandamudi; Michael Lanfranchi; Adel M Malek
Journal:  J Neurosurg       Date:  2013-08-23       Impact factor: 5.115

10.  Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis.

Authors:  Alberto Zanetto; Henry M Rinder; Marco Senzolo; Paolo Simioni; Guadalupe Garcia-Tsao
Journal:  Hepatol Commun       Date:  2020-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.